Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain

BSE362.7031.55 (+9.53 %)

PREV CLOSE ( ) 331.15

OPEN PRICE ( ) 337.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 9068

TODAY'S LOW / HIGH ( )335.00 370.00

52 WK LOW / HIGH ( )282.15 581

NSE363.2530.95 (+9.31 %)

PREV CLOSE( ) 332.30

OPEN PRICE ( ) 333.00

BID PRICE (QTY) 363.25 (272)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 274174

TODAY'S LOW / HIGH( ) 333.00 369.95

52 WK LOW / HIGH ( )281.1 581.9

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

-79.48

14.77

128.05

14493.56

-1450.30

Adjustment

-98.71

-57.35

-958.69

-14549.67

2308.81

Changes In working Capital

-85.81

102.32

-3369.11

3008.63

219.08

Cash Flow after changes in Working Capital

-264.00

59.74

-4199.75

2952.52

1077.59

Cash Flow from Operating Activities

-273.69

34.68

-4224.52

-1084.48

1067.64

Cash Flow from Investing Activities

649.84

66.59

4303.31

12825.73

-476.79

Cash Flow from Financing Activities

-26.64

-28.08

-183.73

-11758.41

-471.10

Net Cash Inflow / Outflow

349.51

73.19

-104.94

-17.16

119.75

Opening Cash & Cash Equivalents

471.74

398.52

503.50

520.79

402.18

Cash & Cash Equivalent on Amalgamation / Take over / Merger

-1.14

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

0.03

-0.04

-0.13

Closing Cash & Cash Equivalent

821.25

471.74

398.52

503.50

520.79